Effects of a pharmacist-led GAIN approach on long-acting injectables in schizophrenia
Journal of the American Pharmacists Association · 2026-07 · 66 (4) · 103143
DOI: 10.1016/j.japh.2026.103143 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Pharmacists Association, 2026-07. Verfasst von Masahide Karashima und 7 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND Long-acting injectable antipsychotics (LAIs) effectively prevent relapse in patients with schizophrenia; however, their utilization rate remains markedly lower in Japan than in other countries. The effectiveness of a pharmacist-led GAIN approach on the initiation and persistence of LAI therapy in Japan has yet to be quantitatively evaluated. METHODS This retrospective observational cohort study examined the effectiveness of the GAIN approach, a structured communication tool led by ward pharmacists to facilitate LAI initiation. We analyzed 180 patients with schizophrenia admitted to our hospital between April 2018 and March 2023 for whom LAI treatment was considered. Outcomes were compared between an intervention group (n = 79), in which pharmacists implemented the GAIN approach, and a non-intervention group (n = 101), in which physicians provided conventional oral explanations. RESULTS The LAI initiation rate was significantly higher in the intervention group than in the non-intervention group (86.1% vs. 59.4%, p < 0.010). Furthermore, the primary endpoint of one-year LAI persistence was significantly higher in the intervention group (88.2% vs. 61.7%, p < 0.010). Within the intervention group, Drug Attitude Inventory-10 and Schedule for Assessment of Insight-Japanese version scores showed significant improvements following the intervention (p < 0.010). CONCLUSIONS These results suggest that a pharmacist-led GAIN approach improves patients' insight and medication attitudes, facilitating both the initiation and long-term maintenance of LAI therapy. In the context of burdened clinical settings, pharmacist involvement via task shifting represents an effective strategy for optimizing psychiatric pharmacotherapy.
Zitieren
APA
Karashima, M., Hiraide, M., Onuma, K., Kamasako, M., Fukasawa, A., Sugi, T., Ishii-Nozawa, R., & Koriki, N. (2026). Effects of a pharmacist-led GAIN approach on long-acting injectables in schizophrenia. Journal of the American Pharmacists Association, 66(4), 103143. https://doi.org/10.1016/j.japh.2026.103143
Vancouver
Karashima M, Hiraide M, Onuma K, Kamasako M, Fukasawa A, Sugi T, et al. Effects of a pharmacist-led GAIN approach on long-acting injectables in schizophrenia. Journal of the American Pharmacists Association. 2026;66(4):103143. doi:10.1016/j.japh.2026.103143
BibTeX
@article{Karashima2026,
author = {Karashima, Masahide and Hiraide, Makoto and Onuma, Kazuhiro and Kamasako, Mayumi and Fukasawa, Akiko and Sugi, Tomiyuki and Ishii-Nozawa, Reiko and Koriki, Norio},
title = {Effects of a pharmacist-led GAIN approach on long-acting injectables in schizophrenia},
journal = {Journal of the American Pharmacists Association},
year = {2026},
volume = {66},
number = {4},
pages = {103143},
doi = {10.1016/j.japh.2026.103143}
}
EUVIMED